ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 35 filers reported holding ADICET BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,683 | -17.9% | 225,316 | +45.7% | 0.00% | 0.0% |
| Q2 2023 | $375,758 | +84.2% | 154,633 | +975.8% | 0.00% | 0.0% |
| Q3 2022 | $204,000 | -95.8% | 14,374 | -95.6% | 0.00% | -93.8% |
| Q2 2022 | $4,808,000 | -38.7% | 329,291 | -16.2% | 0.02% | -30.4% |
| Q1 2022 | $7,844,000 | -36.3% | 392,798 | -44.2% | 0.02% | -11.5% |
| Q4 2021 | $12,306,000 | +1927.3% | 703,605 | +809.0% | 0.03% | +2500.0% |
| Q3 2021 | $607,000 | -56.1% | 77,403 | -42.4% | 0.00% | -66.7% |
| Q2 2021 | $1,383,000 | +3.2% | 134,429 | +31.2% | 0.00% | 0.0% |
| Q1 2021 | $1,340,000 | +250.8% | 102,444 | +276.5% | 0.00% | +200.0% |
| Q4 2020 | $382,000 | +213.1% | 27,208 | +166.1% | 0.00% | – |
| Q3 2020 | $122,000 | – | 10,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |